General Western Blot Reagents
Abcam 2'-Deo x yuridine-5'-monophosphate disodium salt, reference substrate for dUMP analogs, 1G
MW 352.1 g/mol, Purity >98%. Used by the enzyme thymidylate synthetase (TS) (EC 2.1.1.45) for the de novo production of dTMP. Reference substrate in studies of dUMP analogs in potential chemotherapy applications.
The product is subject to the following: Abcam Restricted Use Statement
Abcam BU 224 hydrochloride, Imidazoline I2 binding site allosteric modulator, 10MG
MW 233.69 Da, Purity >99%. High affinity Imidazoline I2 binding site allosteric modulator (Ki = 2.1 nM). Dose-dependently inhibits C-fiber evoked responses, post-discharge and wind-up. Shows antinociceptive effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PRIMA-1MET, p53 activity, 25MG
MW 199.25 Da, Purity >98%. Methylated derivative of PRIMA-1 (ab141641). Restores wild-type conformation and function to mutant p53, and triggers apoptosis in tumor cells. Acts synergistically with chemotherapeutic agents to inhibit tumor cell proliferation. Inhibits thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bis(3,5-dibromosalicyl) fumarate, hemoglobin acylating agent, 100MG
MW 671.9 Da, Purity >93%. Potent hemoglobin acylating agent. Cross-links beta chains of hemoglobin. Acylating and anti-sickling agent. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Sulforhodamine 101 acid chloride, amine-reactive rhodamine dye, 5MG
MW 625.2 Da, Purity >95%. Long wavelength red fluorescent amine-reactive rhodamine dye, also known as Texas Red. Useful for histological staining as well as in cell sorting experiments with fluorescent-activated cell sorting machines (FACS).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Oligomycin A, ATP synthase inhibitor, 1MG
MW 791.1 Da, Purity >97%. Macrolide antibiotic. ATP synthase inhibitor. Blocks the proton channel (Fo subunit) to uncouple oxidative phosphorylation. Shows antitumor activity. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam alpha-Calcitonin Gene Related Peptide (human), CGRP agonist, 1MG
MW 3789.3 Da, Purity >95%. alpha-Calcitonin Gene Related Peptide (human), CGRP agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bufalin, Na+/K+-ATPase inhibitor, 10MG
MW 386.5 Da, Purity >98%. Na+/K+-ATPase inhibitor. Potent steroid receptor coactivators SRC-3 and SRC-1 inhibitor. Induces cell differentiation and apoptosis. Activates AP-1 via JNK. Shows antitumor effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 4-Methylumbelliferyl oleate, Fluorogenic substrate for lipases, 250MG
MW 440.61 g/mol, Purity >95%. Fluorogenic substrate for lipases, which can be used in aqueous solutions as well as several organic solvents.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Scriptaid, HDAC inhibitor, 10MG
MW 326.35 g/mol, Purity >98%. Novel HDAC inhibitor, able to cause >100-fold increase in histone deacetylation. Less toxic than trichostatin A (ab120850). Induces cell cycle arrest in vitro and in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam CRANAD-2, Near-infrared Amyloid-beta fluorescent probe, 25MG
MW 410.3 Da, Purity >98%. Near-infrared (NIR) Amyloid-β fluorescent probe. Upon interacting with Amyloid-β aggregates displays a 70-fold increase in fluorescence intensity accompanied by a 90 nm blue shift from 805 to 715 nm. Demonstrates high affinity for amyloid-β aggregates (Kd = 38 nM). Detects amyloid-β in vitro and in vivo. Blood-brain barrier permeable. Learn more
The product is subject to the following: Abcam Restricted Use Statement
Abcam Deltamethrin, protein phosphatase 2B inhibitor, 50MG
MW 505.2 Da, Purity >98%. Potent protein phosphatase 2B inhibitor (IC₅₀ = 0.03 nM). Induces neurotoxicity by slowing the opening and closing of Na+ channels. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 334867, O x 1 receptor antagonist, 1MG
MW 319.32 Da, Purity >99%. Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Nifedipine, L-type Ca2+ channel blocker, 250MG
MW 346.3 Da, Purity >99%. L-type Ca2+ channel blocker. Potent, long-acting vasodilator. Also shown to inhibit vascular inflammation.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Isradipine, L-type Ca2+ channel blocker, 50MG
MW 371.4 Da, Purity >98%. L-type Ca2+ channel blocker. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement